1. Home
  2. BDSX vs RCAT Comparison

BDSX vs RCAT Comparison

Compare BDSX & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • RCAT
  • Stock Information
  • Founded
  • BDSX 2005
  • RCAT 2002
  • Country
  • BDSX United States
  • RCAT United States
  • Employees
  • BDSX N/A
  • RCAT N/A
  • Industry
  • BDSX Precision Instruments
  • RCAT Wholesale Distributors
  • Sector
  • BDSX Health Care
  • RCAT Industrials
  • Exchange
  • BDSX Nasdaq
  • RCAT Nasdaq
  • Market Cap
  • BDSX 53.0M
  • RCAT 1.5B
  • IPO Year
  • BDSX 2020
  • RCAT 2017
  • Fundamental
  • Price
  • BDSX $6.83
  • RCAT $11.25
  • Analyst Decision
  • BDSX Strong Buy
  • RCAT Strong Buy
  • Analyst Count
  • BDSX 5
  • RCAT 2
  • Target Price
  • BDSX $32.50
  • RCAT $15.00
  • AVG Volume (30 Days)
  • BDSX 280.7K
  • RCAT 13.1M
  • Earning Date
  • BDSX 11-03-2025
  • RCAT 12-15-2025
  • Dividend Yield
  • BDSX N/A
  • RCAT N/A
  • EPS Growth
  • BDSX N/A
  • RCAT N/A
  • EPS
  • BDSX N/A
  • RCAT N/A
  • Revenue
  • BDSX $76,556,000.00
  • RCAT N/A
  • Revenue This Year
  • BDSX $18.78
  • RCAT $883.03
  • Revenue Next Year
  • BDSX $26.42
  • RCAT $110.60
  • P/E Ratio
  • BDSX N/A
  • RCAT N/A
  • Revenue Growth
  • BDSX 25.70
  • RCAT N/A
  • 52 Week Low
  • BDSX $3.44
  • RCAT $2.96
  • 52 Week High
  • BDSX $34.39
  • RCAT $16.70
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 54.95
  • RCAT 48.06
  • Support Level
  • BDSX $6.22
  • RCAT $9.52
  • Resistance Level
  • BDSX $7.00
  • RCAT $11.67
  • Average True Range (ATR)
  • BDSX 0.66
  • RCAT 1.18
  • MACD
  • BDSX -0.19
  • RCAT -0.26
  • Stochastic Oscillator
  • BDSX 50.36
  • RCAT 25.90

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.

Share on Social Networks: